chemocauterization is the therapeutic destruction of abnormal, diseased, granulating, or actively bleeding tissue through direct topical application of a caustic (tissue-corrosive) chemical agent — most commonly silver nitrate, trichloroacetic acid (TCA), or phenol. It differs from electrocauterization, which uses electrical current to generate heat, and from cryocauterization (cryotherapy), which destroys tissue by freezing; chemocauterization instead relies on direct chemical protein denaturation and coagulation necrosis at the point of contact. Mechanistically, the caustic agent precipitates cellular proteins and induces localized coagulative necrosis, sealing small superficial vessels and destroying epithelial or granulation tissue without an external heat or electrical source. The technique spans both physiologically-adjacent, intentional therapeutic destruction — such as controlling epistaxis (R04.0) or ablating excess granulation tissue (proud flesh) in a healing wound, sinus, or fistula — and pathological-target uses, such as destroying anogenital warts (condyloma acuminatum, A63.0) or pyogenic granuloma (L98.0). It is most commonly encountered in coding under CPT 17250 for granulation tissue and under the method-specific “chemical” destruction codes for penile and anal lesions. chemocauterization is frequently confused with fulguration, which specifically denotes electrosurgical destruction by electric sparking rather than chemical contact, and with sclerotherapy, which uses a chemical agent to destroy or occlude blood vessels rather than surface tissue.
Noun-forming suffix — “process or result of doing”
The word chemocauterization is a 20th-century hybrid coinage, joining the combining form chemo- with cauterization, which entered English by the 14th century via Old French cauteriser and Late Latin cauterizare, originally describing the surgical use of a heated iron to seal wounds or destroy tissue. As chemistry emerged as a distinct medical modality in the 19th and early 20th centuries, chemo- was increasingly prefixed onto existing treatment terms — most famously in chemotherapy, coined in the early 1900s by Paul Ehrlich — to specify a chemical (rather than thermal, electrical, mechanical, or cryogenic) mechanism of action. chemocauterization follows this same pattern, distinguishing chemical tissue destruction from its sibling terms electrocauterization (electrical current), thermocauterization (direct heat), and cryocauterization (freezing). The root kaiein also connects chemocauterization to cautery and caustic (Greek kaustikos, “capable of burning”), both describing the same underlying burn-based mechanism regardless of energy source.
🔀 ALIASES / ALTERNATE TERMS
Chemical cauterization(full expanded form; the most common formal synonym used interchangeably in operative and pathology reports)
Chemosurgery(broader term sometimes used for chemical tissue destruction, especially in older CPT-adjacent descriptors; can also refer to Mohs micrographic technique in dermatology — use with care to avoid ambiguity)
Caustic cauterization(descriptive synonym emphasizing the corrosive nature of the agent)
Silver nitrate cauterization(agent-specific subtype; the most common chemocauterizing agent, especially for epistaxis and granulation tissue)
TCA cauterization / trichloroacetic acid cauterization(agent-specific subtype; common for anogenital warts and dermatologic lesions)
🔗 RELATED TERMS
Electrocauterization — uses electric current/heat rather than a chemical agent to destroy tissue; the more common cautery method in modern surgical practice
Cryocauterization / cryotherapy — destroys tissue via extreme cold (e.g., liquid nitrogen); shares many of the same indications (warts, granulation tissue) but a different mechanism
Fulguration — electrosurgical destruction of tissue by electric sparking without direct chemical or thermal contact; frequently confused with chemocauterization in destruction-of-lesion coding
Sclerotherapy — chemical destruction/occlusion of blood vessels (e.g., varicose veins, hemorrhoids) rather than surface epithelial or granulation tissue
cautery — the general parent term for controlled tissue destruction by any burning or corrosive method; shares the cauter- root
Caustic — adjective describing a chemical agent capable of burning or corroding tissue on contact; shares the same root (kaiein) as cautery
Granulation tissue — the vascular, fibroblast-rich reparative tissue that chemocauterization (17250) is most often used to reduce when it overgrows a healing wound, sinus, or fistula
Pyogenic granuloma — a benign vascular lesion of excess granulation tissue (L98.0) frequently treated with chemocauterization or excision
Epistaxis — nosebleed (R04.0); a leading otolaryngology indication for chemocauterization (typically silver nitrate) to control anterior nasal hemorrhage
Condyloma acuminatum — anogenital wart (A63.0) caused by HPV; frequently treated with chemocauterization of the penis or anus
Coagulation necrosis — the histologic pattern of cell death produced by chemocauterization, in which cellular proteins denature while tissue architecture is briefly preserved
Destruction of lesion(s), anus (e.g., condyloma, papilloma, molluscum contagiosum, herpetic vesicle), simple; chemical
⚠️ Coding Note:chemocauterization is a technique, not a stand-alone billable diagnosis, so code selection is driven entirely by anatomic site and method-specificity within the CPT descriptor rather than by the term itself. 17250 is reported once per encounter regardless of the number of granulation-tissue sites treated in the same wound, sinus, or fistula, and it is NCCI-bundled into most surgical wound-repair and debridement codes performed at the same session — do not unbundle it from a same-session excision or repair without a clinically supported, separately identifiable indication and modifier -59/-XS. For anogenital lesion destruction, 54050 (penis) and 46900 (anus) are method-specific “chemical” codes; if the operative note instead documents electrodesiccation, cryosurgery, or laser, the sibling code in that family must be selected instead — a common inpatient profee undercoding trap is defaulting to the “chemical” code when documentation actually supports a different modality. The nasal hemorrhage control codes (30901–30906) are method-agnostic (“any method”) and should not be assumed to require chemocauterization specifically — confirm the documented technique before assigning based on anterior/posterior site and simple/complex extent. Sequence the underlying condition (epistaxis, condyloma, pyogenic granuloma) as the primary diagnosis driving medical necessity; chemocauterization itself carries no independent ICD-10-CM code. Watch for ambiguous documentation such as “cauterized” or “treated with cautery” without specifying chemical vs. electrical method — this should trigger a physician query, since it directly changes CPT code family selection.